RSS Feeds
Search

In-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..2 of 2 - per page
Order by
NCEs, new patented formulations and products
Respiratory; women's care; dermatology; pain relief; GI More
Drug free pain relief devices with additional benefits
A global healthcare company is currently seeking devices that can be used to relieve pain, particularly electrotherapy devices. More
Displaying 1..2 of 2 - per page
Order by

Related Reports

Market Research Reports provided by reports.innovaro.com
Musculoskeletal Disorders Therapeutics to 2016 - Introduction of Monoclonal Antibodies with First - in - class Mechanism of Action to Increase Treatment Options in Osteoporosis and Rheumatoid Arthritis
Oct 2010 - 169 pages - $3,500
Spinal Muscular Atrophy - Pipeline Review, Q4 2010
Dec 2010 - 31 pages - $500
National Institute of Arthritis and Musculoskeletal and Skin Diseases – Developmental Therapeutics Review – Q4 2010
Nov 2010 - 40 pages - $500
Muscular Dystrophy - Pipeline Assessment and Market Forecasts to 2017
Nov 2010 - 41 pages - $2,000
Spinal Muscular Atrophy - Pipeline Review, Q2 2011
Apr 2011 - 50 pages - $500
Spinal Muscular Atrophy (SMA) - Pipeline Review, H2 2011
Aug 2011 - 53 pages - $500
Duchenne Muscular Dystrophy - Pipeline Review, H2 2011
Sep 2011 - 74 pages - $500
Duchenne Muscular Dystrophy - Pipeline Review, Q1 2011
Feb 2011 - 57 pages - $500
Muscular Dystrophy (MD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018
Nov 2011 - 96 pages - $3,500
National Institute of Arthritis and Musculoskeletal and Skin Diseases – Developmental Therapeutics Review – Q4 2010
Dec 2010 - 84 pages - $500
More Related Market Research Reports >>>

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2012 Innovaro Europe Ltd Innovaro Corporation All rights reserved. Terms and Conditions | Contact us